![](/img/cover-not-exists.png)
Muraglitazar, a dual (α/γ) PPAR activator: A randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes
John B. Buse, Cindy J. Rubin, Robert Frederich, Kalyanee Viraswami-Appanna, Kwo-Chuan Lin, Rafael Montoro, Gerald Shockey, Jaime A. DavidsonVolume:
27
Year:
2005
Language:
english
Pages:
1196
DOI:
10.1016/j.clinthera.2005.08.005
File:
PDF, 2.13 MB
english, 2005